` 688315 (Novogene Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

688315
vs
Shanghai Composite

Over the past 12 months, has outperformed Shanghai Composite, delivering a return of 25% compared to the Shanghai Composite's 14% growth.

Stocks Performance
688315 vs Shanghai Composite

Loading
688315
Shanghai Composite
Add Stock
www.alphaspread.com

Performance Gap
688315 vs Shanghai Composite

Loading
688315
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
688315 vs Shanghai Composite

Loading
688315
Shanghai Composite
Add Stock

Competitors Performance
Novogene Co Ltd vs Peers

Shanghai Composite
688315
0KHE
TMO
DHR
207940
Add Stock

Novogene Co Ltd
Glance View

Market Cap
5.6B CNY
Industry
Life Sciences Tools & Services

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. At the same time, based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Intrinsic Value
22.48 CNY
Undervaluation 39%
Intrinsic Value
Price
Back to Top